Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Documenti analoghi

• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
  di: Griffiths, G, et al.
  Pubblicazione: (2009)
• Issues in data monitoring and interim analysis of trials.
  di: Grant, A, et al.
  Pubblicazione: (2005)
• CANparent trial evaluation: second interim report
  di: Cullen, M, et al.
  Pubblicazione: (2014)
• CANparent trial evaluation: First interim report
  di: Cullen, M, et al.
  Pubblicazione: (2013)
• Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
  di: Masahide Oki, et al.
  Pubblicazione: (2024-12-01)